Iron absorption by healthy women is not associated with either serum or urinary prohepcidin

American Journal of Clinical Nutrition

Volumn 84, Issue 1, 2006, Pages 150-155

  Hadley, Kevin B ^a   Johnson, Luann K ^b   Hunt, Janet R ^a,c  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Hepcidin; Iron absorption; Iron status; Postmenopausal women; Prohepcidin; Serum ferritin

Indexed keywords

FERRITIN; HEMOGLOBIN; HEPCIDIN; IRON; PROTEIN PRECURSOR; PROTEIN PROHEPCIDIN; TRANSFERRIN; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; IRON DERIVATIVE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; IRON ABSORPTION; NORMAL HUMAN; PREMENOPAUSE; URINALYSIS; URINE LEVEL; WHOLE BODY SCINTISCANNING; BIOAVAILABILITY; BLOOD; DIET SUPPLEMENTATION; INTESTINE ABSORPTION; IRON INTAKE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; SCINTILLATION COUNTING; URINE;

ADMINISTRATION, ORAL; ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL AVAILABILITY; DIETARY SUPPLEMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INTESTINAL ABSORPTION; IRON COMPOUNDS; IRON RADIOISOTOPES; IRON, DIETARY; MIDDLE AGED; PREMENOPAUSE; PROTEIN PRECURSORS; SCINTILLATION COUNTING;

EID: 33747406251     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/84.1.150     Document Type: Article

References (44)

1. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-9.
2. Nicolas G, Viatte L, Lou DQ, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003;34:97-101.
3. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002;99:4596-601.
4. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 2001;98:8780-5.
5. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-44.
6. Laftah AH, Ramesh B, Simpson RJ, et al. Effect of hepcidin on intestinal iron absorption in mice. Blood 2004;103:3940-4.
7. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2051-3.
8. Yeh KY, Yeh M, Glass J. Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. Am J Physiol Gastrointest Liver Physiol 2004;286:G385-94.
9. Frazer DM, Wilkins SJ, Becker EM, et al. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 2002;123:835-44.
10. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-50.
11. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-10.
12. Zhang AS, Xiong S, Tsukamoto H, Enns CA. Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood 2004;103:1509-14.
13. Kulaksiz H, Gehrke SG, Janetzko A, et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 2004;53:735-43.
14. Kulaksiz H, Theilig F, Bachmann S, et al. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 2005;184:361-70.
15. Lykken GI, Ong HS, Alkhatib HA, Harris TR, Momcilovc B, Penland JG. Perquisite spin-off from twenty-two years of measuring background in the whole body counter steel room. Ann NY Acad Sci 2000;904:267-70.
16. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101:3359-64.
17. Wians FH, Urban JE, Kroft SH, Keffer JH. Soluble transferrin receptor (sTfR) concentration quantified using 2 sTfR kits: analytical and clinical performance characteristics. Clin Chim Acta 2001;303:75-81.
18. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 1973;43:305-10.
19. SAS Institute Inc. Online Doc 9.1.2. Cary, NC: SAS Institute Inc, 2004.
20. Heinrich HC. Intestinal iron absorption in man. Methods of measurement, dose-relationship, diagnostic and therapeutic applications. In: Hallberg L, Harwerth HG, Vanotti A, eds. Iron deficiency, pathogenesis, clinical aspects, and therapy. London-New York: Academic Press, 1970;213-94.
21. Werner E, Roth P, Kaltwasser JP. Relationship between the dose administered and the intestinal absorption of iron from ferrous sulphate in humans. In: Satlman P, Hegenauer J, eds. The biochemistry and physiology of iron. New York, NY: Elsevier Medical, 1982:821-3.
22. Food and Nutrition Board; Institute of Medicine. Dietary Reference Intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, Fe, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press, 2001.
23. Courselaud B, Pigeon C, Inoue Y, et al. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 2002;277:41163-70.
24. Frazer DM, Inglis HR, Wilkins SJ, et al. Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 2004;53:1509-15.
25. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002;100:3776-81.
26. Dallalio G, Fleury T, Means RT. Serum hepcidin in clinical specimens. Br J Haematol 2003;122:996-1000.
27. Hunt JR, Roughead ZK. Adaptation of iron absorption in men consuming diets with high or low iron bioavailability. Am J Clin Nutr 2000;71:94-102.
28. Hunt JR, Zeng H. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Am J Clin Nutr 2004;80:924-31.
29. Kemna EH, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106:1864-6.
30. Detivaud L, Nemeth E, Boudjema K, et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 2005;106:746-8.
31. Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973;26:770-2.
32. Cook JD, Lipschitz DA, Miles LEM, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974;27:681-7.
33. Finch CA, Bellotti V, Stray S, et al. Plasma ferritin determination as a diagnostic tool. West J Med 1986;145:657-63.
34. Hallberg L, Bengtsson C, Lapidus L, Lindstedt G, Lundberg PA, Hulten L. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol 1993;85:787-98.
35. Taylor P, Martinez-Torres C, Leets I, Ramirez J, Garcia-Casal MN, Layrisse M. Relationships among iron absorption, percent saturation of plasma transferrin and serum ferritin concentration in humans. J Nutr 1988;118:1110-5.
36. Lynch SR, Skikne BS, Cook JD. Food iron absorption in idiopathic hemochromatosis. Blood 1989;74:2187-93.
37. Hallberg L, Hulten L, Gramatkovski E. Iron absorption from the whole diet in men: how effective is the regulation of iron absorption? Am J Clin Nutr 1997;66:347-56.
38. Roughead ZK, Hunt JR. Adaptation in iron absorption: iron supplementation reduces nonheme-iron but not heme-iron absorption from food. Am J Clin Nutr 2000;72:982-9.
39. Gehrke SG, Herrmann T, Kulaksiz H, et al. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway. Digestion 2005;72:25-32.
40. Wilkins SJ, Frazer DM, Millard KN, McLaren GD, Anderson GJ. Iron metabolism in the hemoglobin deficit mouse: correlation of diferric transferrin with hepcidin expression. Blood 2005;107:1659-64.
41. Gehrke SG, Kulaksiz H, Herrmann T, et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 2003;102:371-6.
42. Giannetti AM, Bjorkman PJ. HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface. J Biol Chem 2004;279:25866-75.
43. Townsend A, Drakesmith H. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload. Lancet 2002;359:786-90.
44. Frazer DM, Anderson GJ. The orchestration of body iron intake: how and where do enterocytes receive their cues? Blood Cells Mol Dis 2003;30:288-97.